Loading instrument data

Sector rotation · Healthcare

Pharmaceuticals & Health Care Research

15 issuers · saved aggregate context · net foreign flow from the saved 2026-09-30 session

Mcap Δ 1w

-4.1%

YTD -29%

Mcap Δ 1y

-21%

total Rp85.5T

Median PE

7.0×

weighted 11.0×

Max drawdown

-45%

RSD 0.19

Valuation & growth (provider aggregates)

yearly valuation — PB / PE / PS / PCF

Year	PB	PE	PS	PCF
2022	1.89×	11.8×	0.94×	18.66×
2023	1.39×	10.5×	0.81×	9.19×
2024	1.67×	10.3×	0.86×	2.09×
2025	1.54×	9.1×	1.04×	9.07×
2026PB rank 17/33	1.21×	7.0×	0.78×	7.97×

weighted yearly growth — earnings / revenue

Year	Earnings	Revenue
2020	+18%	+3%
2021	-499%	+18%
2022	+130%	+5%
2023	-9%	+4%
2024	+4%	+14%
2025	+11%	+7%
2026forecast	+8%	+10%

Strongest 1-month movers

Issuer	Δ 1m	Δ 1y	PE	Close
SOHO	+8.4%	+65%	24.1×	1295
PEVE	+3.8%	-36%	10.0×	324
DVLA	+0.3%	-2%	13.0×	1585
MDLA	+0.0%	-8%	7.0×	208
SCPI	+0.0%	+0%	0.3×	29000

Monthly mcap performance

25-10

+24%

Net foreign flow over members on 2026-09-30: −Rp4.7B. Members without stored flow rows count as zero.

Member issuers (15) · with positioning score

Issuer	Industry	Index
OBAT	Pharmaceuticals	+6
KAEF	Pharmaceuticals	+3
DVLA	Pharmaceuticals	0
IKPM	Pharmaceuticals	0
PEVE	Pharmaceuticals	0
SOHO	Pharmaceuticals	0
TSPC	Pharmaceuticals	0
PEHA	Pharmaceuticals	-1
MERK	Pharmaceuticals	-2
MDLA	Pharmaceuticals	-4
PYFA	Pharmaceuticals	-8
KLBF	Pharmaceuticals	-15
SIDO	Pharmaceuticals	-55
INAF	Pharmaceuticals	Unavailable
SCPI	Pharmaceuticals	Unavailable